Eton Pharmaceuticals Is A Commercial Stage Pharmaceutical Company Based In Deer Parkillinoisfocused On Developing And Commercializing Therapies For Rare Diseasesparticularly In Pediatric Populationsfounded In 2017Eton Employs A Rare Disease First Strategyprioritizing Small Patient Groups Where Innovative Treatments Can Make A Significant Impactthe Company Is Dedicated To Efficient Navigation Of Fda Approval Processes To Meet Urgent Patient Needs Eton Specializes In Drug Developmentreformulating Existing Medications Into New Dosage Forms To Improve Patient Complianceits Portfolio Includes Fda Approved Products Like Alkindi Sprinklea A Glucocorticoid Replacement Therapy For Pediatric Adrenal Insufficiencyand Zonisadea An Oral Suspension For Epilepsythe Company Is Also Developing The Zeneo Hydrocortisone Autoinjector For Adrenal Crisis Management And Has Other Products Under Revieweton Collaborates With Healthcare Providers To Address The Needs Of Patients With Rare Diseasesfocusing On Conditions Such As Adrenal Insufficiencyepilepsyand Methanol Poisoning
